TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma

Liver cancer biopsy - back to the future?!

(2015) Michael Torbenson et al.   HEPATOLOGY

261 VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PREDICTOR OF RESPONSE TO THE COMBINED THERAPY WITH SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

(2013) D. Lee et al.   JOURNAL OF HEPATOLOGY

Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia

(2012) Delphine Tamara Marie-Egyptienne et al.   CANCER LETTERS

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

(2012) Armando Santoro et al.   LANCET ONCOLOGY

Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy

(2012) Nikolaus Kohles et al.   TUMOR BIOLOGY

Best radiological response to trans‐arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes

(2012) Jon C. Henry et al.   HPB

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

(2011) Roopinder Gillmore et al.   JOURNAL OF HEPATOLOGY

Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation

(2011) Chikako Zen et al.   LIVER TRANSPLANTATION

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

(2010) X.-R. Yang et al.   GUT

Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma

(2010) Hélène Marijon et al.   JOURNAL OF HEPATOLOGY

Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic–pathologic correlation

(2010) Ahsun Riaz et al.   JOURNAL OF HEPATOLOGY

New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation

(2010) P Swietach et al.   ONCOGENE

Radiologic–Pathologic Correlation of Hepatocellular Carcinoma Treated with Chemoembolization

(2009) Ahsun Riaz et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria

(2008) M. Ravaioli et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis

(2008) Francis Y. Yao et al.   HEPATOLOGY